Trade Summary

1 week ago, Seidenberg Beth C, serving as Dir at Kyverna Therapeutics, Inc. (KYTX), purchased 133,333 shares at $7.50 per share, for a total transaction value of $999,998.00. Following this transaction, Seidenberg Beth C now holds 4,673,891 shares of KYTX.

This purchase represents a 3.00% increase in Seidenberg Beth C's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Thursday, December 18, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 22, 2025, 4 days after the trade was made.

Kyverna Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.